Cell Therapy for Parkinson's Disease: What Next?

Anders Bjorklund, Jeffrey H. Kordower

Research output: Contribution to journalReview articlepeer-review

59 Scopus citations


The idea to use transplants of dopamine-producing cells to substitute for the lost midbrain dopamine neurons in Parkinson's disease (PD) goes back to the 1970s. In this review we give an overview of the history of cell transplantation in animal models of PD, and summarize the experience gained from the open-label and placebo-controlled clinical trials performed so far using intrastriatal transplants of human fetal dopamine neuroblasts. Further development of this therapeutic approach face numerous challenges, for example in the development of protocols that allow generation of fully functional and safe midbrain dopamine neurons from stem cells. Based on recent promising advancements, efforts are now being made to develop standardized and efficient protocols, and adapt these protocols to good laboratory practice (GLP)/good manufacturing practice (GMP) conditions, to move this technology closer to clinical translation.

Original languageEnglish (US)
Pages (from-to)110-115
Number of pages6
JournalMovement Disorders
Issue number1
StatePublished - Jan 2013
Externally publishedYes


  • Clinical trials
  • Dopamine
  • Transplantation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Cell Therapy for Parkinson's Disease: What Next?'. Together they form a unique fingerprint.

Cite this